U.S. Communications Stock News

NYSE:LDI
NYSE:LDIDiversified Financial

Promising Penny Stocks To Consider In February 2026

As February begins, U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. While larger market trends capture headlines, investors often overlook smaller opportunities such as penny stocks, which despite their vintage name, continue to offer potential for significant returns when backed by solid financials. This article explores three promising penny stocks that combine balance sheet strength with...
NYSE:MCB
NYSE:MCBBanks

Undiscovered Gems in the US Market Featuring 3 Promising Stocks

As the U.S. stock market kicks off February with a notable upswing, highlighted by the Dow Jones Industrial Average's 515-point gain and the S&P 500 nearing record highs, investors are keenly observing how economic shifts and policy changes might impact small-cap stocks. Amidst this backdrop of optimism and strategic trade deals, identifying promising opportunities in lesser-known stocks can be an effective strategy for those looking to diversify their portfolios in today's dynamic market...
NYSE:SPNT
NYSE:SPNTInsurance

A Look At SiriusPoint (SPNT) Valuation After Strong Turnaround In Latest Earnings Results

Why SiriusPoint’s latest earnings matter for shareholders SiriusPoint (SPNT) has put fresh financial results on the table, and they are a clear shift from the prior year. For you as a shareholder, the size of that shift is the starting point. See our latest analysis for SiriusPoint. The latest earnings release comes after a 1-year total shareholder return of 46.82% and a very large 3-year total shareholder return of 192.19%. However, the 90-day share price return of 4.15% suggests momentum...
NYSE:CNK
NYSE:CNKEntertainment

Cinemark Holdings CNK Margin Slide Challenges Bullish Profitability Narratives After FY 2025 Q3 Results

Cinemark Holdings (CNK) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of US$857.5 million and EPS of US$0.43, following Q2 revenue of US$940.5 million and EPS of US$0.81, and a Q1 loss of US$0.32 per share on revenue of US$540.7 million. The company has seen revenue move from US$734.2 million in Q2 2024 to US$921.8 million in Q3 2024, alongside EPS shifting from US$0.37 to US$1.54 over that stretch, so investors are likely to focus on how current margins stack up against that...
NYSE:SMR
NYSE:SMRElectrical

Assessing NuScale Power (SMR) After A 33% One Year Share Price Decline

If you are wondering whether NuScale Power's current share price lines up with its underlying value, you are not alone and that is exactly what this article is here to unpack. The stock recently closed at US$14.20, with returns of 8.8% decline over 7 days, 29.7% decline over 30 days, 12.9% decline year to date and 32.8% decline over 1 year, set against a 38.5% return over 3 years and 31.5% over 5 years. These mixed returns sit against a backdrop of ongoing attention on NuScale Power's role...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Produce (FDP) Earnings Hit One Off Loss That Fuels Margin Debate

Fresh Del Monte Produce (FDP) has reported a mixed set of FY 2025 numbers, with Q3 revenue of US$1.0b and a basic EPS loss of US$0.61, set against trailing 12 month EPS of US$1.65 and net income of US$79.2m. The company has seen quarterly revenue move between US$1.0b and US$1.2b over the last six reported periods, while basic EPS has ranged from a loss of US$0.61 to a high of US$1.18. The latest quarter therefore lands at the weaker end of that spectrum and leaves investors focused on how...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Constellium (CSTM) Margin Compression To 1.4% Tests Bullish Profitability Narratives

Constellium FY 2025 Results: Revenue Steady, Earnings Volatile Constellium (CSTM) just posted another quarter of mixed numbers, with Q3 2025 revenue at US$2.2b, basic EPS of US$0.63 and net income of US$88m. The latest trailing twelve month figures show revenue of about US$8.0b and EPS of US$0.80 alongside a net margin of 1.4% compared to 1.8% the prior year. Over recent quarters, the company has seen revenue move from US$1.8b in Q3 2024 to US$2.2b in Q3 2025. Quarterly EPS has swung from a...
NYSE:TPL
NYSE:TPLOil and Gas

Is It Too Late To Consider Texas Pacific Land (TPL) After Its Sharp Recent Rally

If you are wondering whether Texas Pacific Land is attractively priced or simply expensive for what you get, you are in the right place to unpack what the current share price might be implying. The stock closed at US$440.71, with returns of 6.6% over 7 days, 30.6% over 30 days, 47.9% year to date, while the 1 year return stands at a 5.3% decline and the 3 year and 5 year returns are 129.4% and 268.9% respectively. Recent news around Texas Pacific Land has focused on its position within the...
NYSE:KTB
NYSE:KTBLuxury

Kontoor Brands Balances Executive Protections With Ongoing Dividend And Valuation Upside

Kontoor Brands (NYSE:KTB) has adopted an Executive Severance Plan, formalizing protections for senior leadership in certain termination scenarios. The board also approved a quarterly dividend, continuing the return of capital to shareholders. These moves come as the company’s shares trade at $67.85, with a mixed return profile across different time frames. Kontoor Brands is pairing governance changes with ongoing shareholder payouts at a time when the stock has a varied track record...
NasdaqGM:CVAC
NasdaqGM:CVACBiotechs

CureVac (CVAC) Valuation Check After Phase 1 Brain Cancer Vaccine Milestone

Why CureVac's latest trial milestone matters for shareholders CureVac (CVAC) has completed a Phase 1 clinical study for its CVGBM mRNA based brain cancer vaccine in patients with surgically resected glioblastoma or astrocytoma, marking a key early checkpoint for its oncology pipeline. See our latest analysis for CureVac. The completion of the CVGBM Phase 1 study comes after a sharp 14.32% 1 day share price decline and a 19.18% 7 day share price return. However, CureVac’s year to date share...
NYSE:PSN
NYSE:PSNProfessional Services

Parsons (PSN) Is Up 5.8% After Landing Key U.S. Cyber Command Contract Intent - What's Changed

In February 2026, Parsons Corporation reported fourth-quarter and full-year 2025 results showing lower sales but slightly higher net income year-on-year, while also issuing 2026 revenue guidance of US$6.5 billion to US$6.8 billion and securing several new U.S. defense and security contracts, including a US$125 million Army research award and a US$91 million State Department security extension. Shortly after these mixed results and contract wins, Parsons’ Sealing Technologies unit received an...
NYSE:JLL
NYSE:JLLReal Estate

JLL (JLL) Net Margin Improvement Challenges Longstanding Bearish Earnings Narratives

Jones Lang LaSalle (JLL) has put up a busy FY 2025 so far, with Q3 revenue at US$6.5b and basic EPS of US$4.71, alongside trailing 12 month revenue of US$25.3b and EPS of US$13.31 that captures the broader earnings cycle. Over recent quarters the company has seen revenue move from US$5.7b and EPS of US$1.17 in Q1 2025 to US$6.3b and EPS of US$2.37 in Q2, and then to US$6.5b and EPS of US$4.71 in Q3, with a 32.1% earnings increase over the past year setting the backdrop for a business where...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Halozyme Therapeutics (HALO) Q4 Loss On US$451.8m Revenue Tests ENHANZE Profit Narrative

Halozyme Therapeutics (HALO) closed out FY 2025 with fourth quarter revenue of US$451.8 million and a basic EPS loss of US$1.20, compared with Q4 2024 revenue of US$298.0 million and basic EPS of US$1.08. Over the past year, the company has seen quarterly revenue move from US$290.1 million in Q3 2024 to US$354.3 million in Q3 2025, while basic EPS shifted from US$1.08 to US$1.49 over the same quarters, creating a mixed picture for margins as investors digest the latest numbers. See our full...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos (GKOS) Q4 EPS Loss Of US$2.32 Tests Bullish Profitability Narratives

Glaukos (GKOS) has just posted its FY 2025 numbers with Q4 revenue of US$143.1 million and a basic EPS loss of US$2.32, alongside a trailing twelve month revenue line of US$507.4 million and a basic EPS loss of US$3.28. Over recent quarters, the company has seen revenue move from US$96.7 million in Q3 2024 to US$105.5 million in Q4 2024 and then to US$143.1 million in Q4 2025, while quarterly basic EPS losses shifted from US$0.39 in Q3 2024 to US$0.60 in Q4 2024 and US$2.32 in Q4 2025. For...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

AtriCure (ATRC) Turns Q4 Profit And Tests Bullish Earnings Growth Narratives

AtriCure (ATRC) just posted its FY 2025 numbers with Q4 revenue of US$140.5 million and basic EPS of US$0.04 on net income of US$1.8 million, while on a trailing twelve month basis the company remains loss making with basic EPS at US$0.24 and net income of US$11.4 million. The company has seen quarterly revenue move from US$124.3 million in Q4 2024 to US$140.5 million in Q4 2025. Over the same periods, basic EPS shifted from a loss of US$0.33 to a small profit of US$0.04. This sets up a story...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

E-Commerce Today - AI Shopping Assistants Transform Online Consumer Experience

Comparor has announced the launch of its AI-powered shopping assistant, a tool designed to streamline the online shopping process by offering instant product recommendations and real-time price comparisons across multiple retailers. This solution leverages artificial intelligence to process natural language requests and deliver optimized shopping options, helping users save time and make more informed purchasing decisions. As an emerging trend in e-commerce, AI-enabled tools like Comparor’s...
NasdaqGS:ANDE
NasdaqGS:ANDEConsumer Retailing

Andersons (ANDE) Thin 0.9% Net Margin Reinforces Bearish Low Profitability Narrative

Andersons (ANDE) has just wrapped up FY 2025 with fourth quarter revenue of US$2.5 billion, basic EPS of US$1.98 and net income of US$67.4 million. Trailing twelve month revenue came in at about US$11.0 billion with EPS of US$2.81. Over recent quarters the company has seen quarterly revenue move between US$2.5 billion and US$3.1 billion, with EPS ranging from close to flat at US$0.01 in Q1 2025 to US$1.98 in Q4. This creates a backdrop where modest net profit margins and small shifts in...
NYSE:DIN
NYSE:DINHospitality

February 2026's Undervalued Small Caps With Insider Actions To Consider

As February 2026 begins, U.S. stock markets have shown resilience with major indices like the Dow Jones and S&P 500 ending sharply higher, buoyed by positive economic indicators such as an unexpected expansion in factory activity. In this dynamic environment, small-cap stocks present intriguing opportunities for investors seeking value and growth potential, especially when insider actions suggest confidence in a company's prospects amidst broader market optimism.